Drug repurposing against antibiotic resistant bacterial pathogens

M Aggarwal, A Patra, I Awasthi, A George… - European Journal of …, 2024 - Elsevier
The growing prevalence of MDR and XDR bacterial pathogens is posing a critical threat to
global health. Traditional antibiotic development paths have encountered significant …

CRISPR-Based Gene Editing in Acinetobacter baumannii to Combat Antimicrobial Resistance

M Junaid, K Thirapanmethee, P Khuntayaporn… - Pharmaceuticals, 2023 - mdpi.com
Antimicrobial resistance (AMR) poses a significant threat to the health, social, environment,
and economic sectors on a global scale and requires serious attention to addressing this …

[HTML][HTML] Epigenetic therapeutics in dental pulp treatment: Hopes, challenges and concerns for the development of next-generation biomaterials

HF Duncan, Y Kobayashi, M Kearney, E Shimizu - Bioactive Materials, 2023 - Elsevier
This opinion-led review paper highlights the need for novel translational research in vital-
pulp-treatment (VPT), but also discusses the challenges in translating evidence to clinics …

Strategic re-engineering of antibiotics

JA Homer, RM Johnson, RA Koelln… - Nature Reviews …, 2024 - nature.com
Multidrug-resistant bacteria, especially those that defy even last-resort antibiotics, are
causing a global health crisis fuelled by antibiotic overuse and misuse as well as the lack of …

Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii …

SS Jean, CY Liu, TY Huang, CC Lai, IM Liu… - Expert Review of Anti …, 2024 - Taylor & Francis
ABSTRACT Introduction Acinetobacter baumannii complex (Abc) is currently a significant
cause of difficult-to-treat pneumonia. Due to the high prevalence rates of carbapenem-and …

Polymyxin B-Enriched Exogenous Lung Surfactant: Thermodynamics and Structure

N Královič-Kanjaková, A Asi Shirazi, L Hubčík… - Langmuir, 2024 - ACS Publications
The use of an exogenous pulmonary surfactant (EPS) to deliver other relevant drugs to the
lungs is a promising strategy for combined therapy. We evaluated the interaction of …

[HTML][HTML] Potential Synergy of Fluoxetine and Antibacterial Agents Against Skin and Soft Tissue Pathogens and Drug-Resistant Organisms

SA Ahmed, RL Jordan, RR Isseroff, JR Lenhard - Antibiotics, 2024 - mdpi.com
Background/Objectives: The feasibility of repurposing selective serotonin reuptake inhibitors
as adjunctive antibacterial agents is an area of current investigation. We sought to evaluate …

[HTML][HTML] Drug metabolism of ciprofloxacin, ivacaftor, and raloxifene by Pseudomonas aeruginosa cytochrome P450 CYP107S1

SE Kandel, BC Tooker, JN Lampe - Journal of Biological Chemistry, 2024 - Elsevier
Drug metabolism is one of the main processes governing the pharmacokinetics and toxicity
of drugs via their chemical biotransformation and elimination. In humans, the liver, enriched …

Bifunctional antibiotic hybrids: A review of clinical candidates

AJJ Koh, V Thombare, M Hussein, GG Rao… - Frontiers in …, 2023 - frontiersin.org
Antibiotic resistance is a top threat to human health and a priority across the globe. This
problematic issue is accompanied by the decline of new antibiotics in the pipeline over the …

Rifabutin: a repurposed antibiotic with high potential against planktonic and biofilm staphylococcal clinical isolates

M Ferreira, M Pinto, F Aires-da-Silva… - Frontiers in …, 2024 - frontiersin.org
Staphylococcus aureus poses a significant threat as an opportunistic pathogen in humans,
and animal medicine, particularly in the context of hospital-acquired infections (HAIs) …